Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): A multicentre, randomised, double-blind, placebo-controlled trial

The Lancet

Volumn 387, Issue 10014, 2016, Pages 136-145

  Weisz, Giora ^a,b,d   Généreux, Philippe ^d,e   Iñiguez, Andres ^f   Zurakowski, Aleksander ^g   Shechter, Michael ^h   Alexander, Karen P ⁱ   Dressler, Ovidiu ^d   Osmukhina, Anna ^j   James, Stefan ^j   Ohman, E Magnus ⁱ   Ben Yehuda, Ori ^d   Farzaneh Far, Ramin ^j   Stone, Gregg W ^c,d  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b NewYork Presbyterian Hospital   (United States)

^c CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^d HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^e HOSPITAL DO MEIXOEIRO   (Spain)

^f American Heart of Poland SA   (Poland)

^g SHEBA MEDICAL CENTER   (Israel)

^h DUKE CLINICAL RESEARCH INSTITUTE   (United States)

ⁱ GILEAD SCIENCES   (United States)

^j UPPSALA UNIVERSITY   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RANOLAZINE; SODIUM CHANNEL BLOCKING AGENT;

ACUTE CORONARY SYNDROME; AGE DISTRIBUTION; AGED; ANGINA PECTORIS; ARTICLE; CEREBROVASCULAR ACCIDENT; CONSTIPATION; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EUROPE; FEMALE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPOTENSION; INCIDENCE; INTENTION TO TREAT ANALYSIS; ISRAEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RUSSIAN FEDERATION; SUDDEN CARDIAC DEATH; TRANSIENT ISCHEMIC ATTACK; UNITED STATES; VERTIGO; VOMITING; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENOSIS; HOSPITALIZATION; ISCHEMIC ATTACK, TRANSIENT; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; STATISTICS AND NUMERICAL DATA; STROKE;

AGED; ANGINA PECTORIS; CORONARY ARTERY DISEASE; CORONARY STENOSIS; DOUBLE-BLIND METHOD; FEMALE; HOSPITALIZATION; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PERCUTANEOUS CORONARY INTERVENTION; RANOLAZINE; SODIUM CHANNEL BLOCKERS; STROKE;

EID: 84954077103     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00459-6     Document Type: Article

References (31)

1. D Mozaffarian, EJ Benjamin, AS Go et al. Heart disease and stroke statistics - 2015 update: a report from the American Heart Association Circulation 131 2015 e29 322
2. GF Rosner, AJ Kirtane, P Genereux et al. Impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute coronary syndromes: the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial Circulation 125 2012 2613 2620
3. P Genereux, T Palmerini, A Caixeta et al. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score J Am Coll Cardiol 59 2012 2165 2174
4. M Gossl, DP Faxon, MR Bell, DR Holmes, BJ Gersh Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease Circ Cardiovasc Interv 5 2012 597 604
5. EL Hannan, M Racz, DR Holmes et al. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era Circulation 113 2006 2406 2412
6. EL Hannan, C Wu, G Walford et al. Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes JACC Cardiovasc Interven 2 2009 17 25
7. C Wu, AM Dyer, SB King III et al. Impact of incomplete revascularization on long-term mortality after coronary stenting Circ Cardiovasc Interven 4 2011 413 421
8. MJ van den Brand, BJ Rensing, MA Morel et al. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial J Am Coll Cardiol 39 2002 559 564
9. GB Mancini, ER Bates, DJ Maron et al. Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial Circ Cardiovasc Qual Outcomes 2 2009 320 327
10. RD Vieira, W Hueb, BJ Gersh et al. Effect of complete revascularization on 10-year survival of patients with stable multivessel coronary artery disease: MASS II trial Circulation 126 2012 S158 S163
11. E Nikolsky, L Gruberg, CV Patil et al. Percutaneous coronary interventions in diabetic patients: is complete revascularization important? J Invasive Cardiol 16 2004 102 106
12. F Hussain, RK Philipp, RA Ducas et al. The ability to achieve complete revascularization is associated with improved in-hospital survival in cardiogenic shock due to myocardial infarction: Manitoba cardiogenic SHOCK Registry investigators Catheter Cardiovasc Interv 78 2011 540 548
13. AH Gershlick, JN Khan, DJ Kelly et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial J Am Coll Cardiol 65 2015 963 972
14. DS Wald, JK Morris, NJ Wald et al. Randomized trial of preventive angioplasty in myocardial infarction N Engl J Med 369 2013 1115 1123
15. JA McPherson, A Maehara, G Weisz et al. Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention JACC Cardiovasc Imaging 5 2012 S76 S85
16. SJ Head, MJ Mack, DR Holmes Jr et al. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data Eur J Cardiothorac Surg 41 2012 535 541
17. L Belardinelli, JC Shryock, H Fraser Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine Heart 92 2006 iv6 i14
18. BR Chaitman, SL Skettino, JO Parker et al. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina J Am Coll Cardiol 43 2004 1375 1382
19. BR Chaitman, CJ Pepine, JO Parker et al. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial JAMA 291 2004 309 316
20. PH Stone, NA Gratsiansky, A Blokhin, IZ Huang, L Meng ERICA Investigators Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial J Am Coll Cardiol 48 2006 566 575
21. DA Morrow, BM Scirica, E Karwatowska-Prokopczuk et al. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial JAMA 297 2007 1775 1783
22. JA Gutierrez, E Karwatowska-Prokopczuk, SA Murphy et al. Effects of ranolazine in patients with chronic angina in patients with and without percutaneous coronary intervention for acute coronary syndrome: observations from the MERLIN-TIMI 36 trial Clin Cardiology 38 2015 469 475
23. MJ Zellweger, G Fahrni, M Ritter et al. Prognostic value of "routine" cardiac stress imaging 5 years after percutaneous coronary intervention: the prospective long-term observational BASKET (Basel Stent Kosteneffektivitats Trial) LATE IMAGING study JACC Cardiovasc Interv 7 2014 615 621
24. GW Stone, A Maehara, AJ Lansky et al. A prospective natural-history study of coronary atherosclerosis N Engl J Med 364 2011 226 235
25. G Weisz, R Farzaneh-Far, O Ben-Yehuda et al. Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial Am Heart J 166 2013 953 959 e3.
26. V Farooq, PW Serruys, CV Bourantas et al. Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score Circulation 128 2013 141 151
27. PA Tonino, B De Bruyne, NH Pijls et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention N Engl J Med 360 2009 213 224
28. B De Bruyne, WF Fearon, NH Pijls et al. Fractional flow reserve-guided PCI for stable coronary artery disease N Engl J Med 371 2014 1208 1217
29. H Fraser, L Belardinelli, L Wang, PE Light, JJ McVeigh, AS Clanachan Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts J Mol Cell Cardiol 41 2006 1031 1038
30. J Wittes On looking at subgroups Circulation 119 2009 912 915
31. Gilead Ranolazine prescribing information: 8.5 geriatric use http://www.gilead.com/∼/media/Files/pdfs/medicines/cardiovascular/ranexa/ranexa-pi.ashx 2013 (accessed Sept 1, 2015).